Peter Ellmark
21 – 30 of 54
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Selective FcγR engagement by human agonistic anti-CD40 antibodies
(
- Contribution to journal › Debate/Note/Editorial
- 2015
-
Mark
Kick-starting the cancer-immunity cycle by targeting CD40
(
- Contribution to journal › Debate/Note/Editorial
- 2014
-
Mark
Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo.
(
- Contribution to journal › Article
-
Mark
Locally Delivered CD40 Agonist Antibody Accumulates in Secondary Lymphoid Organs and Eradicates Experimental Disseminated Bladder Cancer.
(
- Contribution to journal › Article
- 2009
-
Mark
Attovial-based antibody nanoarrays.
(
- Contribution to journal › Article
- 2008
-
Mark
Detection of pancreatic cancer using antibody microarray-based serum protein profiling
(
- Contribution to journal › Article
-
Mark
Multiplexed Lipid Dip-Pen Nanolithography on Subcellular Scales for the Templating of Functional Proteins and Cell Culture
(
- Contribution to journal › Article
-
Mark
Identification of a strongly activating human anti-CD40 antibody that suppresses HIV-1 infection
(
- Contribution to journal › Article
-
Mark
Sensitivity of HIV-1 primary isolates to human anti-CD40 antibody-mediated suppression is related to co-receptor use
(
- Contribution to journal › Article
-
Mark
The Applicability of a Cluster of Differentiation Monoclonal Antibody Microarray to the Diagnosis of Human Disease
(
- Contribution to journal › Article